Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1964 1
1974 1
1979 2
1980 1
1982 2
1983 6
1984 2
1985 3
1986 3
1988 3
1989 2
1990 12
1991 8
1992 11
1993 4
1994 2
1995 10
1996 7
1997 5
1998 5
1999 4
2000 3
2001 3
2002 9
2003 6
2004 3
2005 4
2006 3
2007 3
2008 9
2009 6
2010 5
2011 9
2012 5
2013 5
2014 4
2015 10
2016 13
2017 7
2018 10
2019 4
2020 3
2021 3
2022 2
Text availability
Article attribute
Article type
Publication date

Search Results

203 results
Results by year
Filters applied: . Clear all
Page 1
Recent advances in treatment for colorectal liver metastasis.
Oki E, Ando K, Nakanishi R, Sugiyama M, Nakashima Y, Kubo N, Kudou K, Saeki H, Nozoe T, Emi Y, Maehara Y. Oki E, et al. Among authors: emi y. Ann Gastroenterol Surg. 2018 Apr 17;2(3):167-175. doi: 10.1002/ags3.12071. eCollection 2018 May. Ann Gastroenterol Surg. 2018. PMID: 29863162 Free PMC article. Review.
Angiogenesis as a target for gastric cancer.
Kakeji Y, Maehara Y, Sumiyoshi Y, Oda S, Emi Y. Kakeji Y, et al. Among authors: emi y. Surgery. 2002 Jan;131(1 Suppl):S48-54. doi: 10.1067/msy.2002.119304. Surgery. 2002. PMID: 11821787 Review.
Effects of an elemental diet to reduce adverse events in patients with esophageal cancer receiving docetaxel/cisplatin/5-fluorouracil: a phase III randomized controlled trial-EPOC 2 (JFMC49-1601-C5).
Tanaka Y, Takeuchi H, Nakashima Y, Nagano H, Ueno T, Tomizuka K, Morita S, Emi Y, Hamai Y, Hihara J, Saeki H, Oki E, Kunisaki C, Otsuji E, Baba H, Matsubara H, Maehara Y, Kitagawa Y, Yoshida K. Tanaka Y, et al. Among authors: emi y. ESMO Open. 2021 Oct;6(5):100277. doi: 10.1016/j.esmoop.2021.100277. Epub 2021 Oct 6. ESMO Open. 2021. PMID: 34626918 Free PMC article. Clinical Trial.
Safety and efficacy of S-1 plus oxaliplatin 130 mg/m2 combination therapy in patients with previously untreated HER2-negative unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: a phase II trial (KSCC1501A).
Kashiwada T, Shinozaki K, Ueno S, Kawanaka H, Uno F, Okita Y, Fukahori M, Matsushita H, Emi Y, Shimokawa M, Makiyama A, Saeki H, Oki E, Maehara Y, Mori M, Baba E; Kyushu Study Group of Clinical Cancer (KSCC). Kashiwada T, et al. Among authors: emi y. Int J Clin Oncol. 2021 Feb;26(2):345-354. doi: 10.1007/s10147-020-01803-w. Epub 2020 Oct 21. Int J Clin Oncol. 2021. PMID: 33085058 Clinical Trial.
203 results